sarepta therapeutics elevidys - Search News

Order byBest matchMost fresh

News

FDA to Ask Sarepta to Halt Elevidys Shipments

· 42m · on MSN

FDA to Ask Sarepta to Halt Elevidys Shipments After Deaths

The Food and Drug Administration plans to ask Sarepta Therapeutics Inc. to pause shipments of its Elevidys treatment after three deaths were linked to the company’s gene therapies, according to a person familiar with the matter.

Continue reading

· 4h · on MSN

Exclusive: US FDA to request Sarepta to stop all shipments of gene therapy Elevidys, source says

FDA to request Sarepta Therapeutics halt shipments of Duchenne gene therapy

3h

Sarepta: Despite Restructuring, Downgrading To Sell After Latest Developments

The restructuring enacted by Sarepta Therapeutics is expected to save up to $400 million in annual costs. Read why I'm ...

9hon MSN

Sarepta Therapeutics Stock Tumbles on Report of Third Death in Clinical Trial

Shares of Sarepta Therapeutics plummeted nearly 30% premarket Friday following a report that a third patient has died during ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results